Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lynn

Showing results (221-230 of 240) with videos related to

Pageof 24
Sort By:
Molecular Cell|July 24, 2012
Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell populationHasan Korkaya, Gwang-Il Kim, April Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2020
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105Dawn L Hershman, Joseph M Unger, Grace Clarke Hillyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2020
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast CancerAranzazu Fernandez-Martinez, Ian E Krop, David W Hillman, et al.
The Oncologist|March 9, 2021
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial CarcinomasRichard S P Huang, James Haberberger, Lukas Harries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCarolyn D Runowicz, Corinne R Leach, N Lynn Henry, et al.
CA: a Cancer Journal for Clinicians|December 8, 2015
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCarolyn D Runowicz, Corinne R Leach, N Lynn Henry, et al.
JCO Precision Oncology|July 29, 2024
TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast CancerChristos Vaklavas, Cindy B Matsen, Zhengtao Chu, et al.
Journal of the National Cancer Institute|October 1, 2011
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupMitch Dowsett, Torsten O Nielsen, Roger A'Hern, et al.
Breast Cancer Research and Treatment|November 2, 2011
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancerAditya Bardia, Erin T Arieas, Zhe Zhang, et al.
JAMA Network Open|April 10, 2026
Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage CancerMeghna S Trivedi, Joseph M Unger, N Lynn Henry, et al.
Pageof 24

Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
Molecular Cell|July 24, 2012
Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell populationHasan Korkaya, Gwang-Il Kim, April Davis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2020
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105Dawn L Hershman, Joseph M Unger, Grace Clarke Hillyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2020
Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast CancerAranzazu Fernandez-Martinez, Ian E Krop, David W Hillman, et al.
The Oncologist|March 9, 2021
Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial CarcinomasRichard S P Huang, James Haberberger, Lukas Harries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCarolyn D Runowicz, Corinne R Leach, N Lynn Henry, et al.
CA: a Cancer Journal for Clinicians|December 8, 2015
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care GuidelineCarolyn D Runowicz, Corinne R Leach, N Lynn Henry, et al.
JCO Precision Oncology|July 29, 2024
TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast CancerChristos Vaklavas, Cindy B Matsen, Zhengtao Chu, et al.
Journal of the National Cancer Institute|October 1, 2011
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working groupMitch Dowsett, Torsten O Nielsen, Roger A'Hern, et al.
Breast Cancer Research and Treatment|November 2, 2011
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancerAditya Bardia, Erin T Arieas, Zhe Zhang, et al.
JAMA Network Open|April 10, 2026
Risk Prediction Model for Taxane-Induced Peripheral Neuropathy in Early-Stage CancerMeghna S Trivedi, Joseph M Unger, N Lynn Henry, et al.
Pageof 24